S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RAPT RAPT Therapeutics Inc

1.80

0.07 (4.05%)

After Hours

Last Updated: 16:19:16

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more RAPT Therapeutics Charts.

RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more RAPT Therapeutics Charts.

RAPT Therapeutics Inc News

Form 8-K - Current report
Monday 23 December 2024 (3 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Monday 23 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (3 days ago) • Edgar (US Regulatory)

RAPT Therapeutics Announces $150 Million Private Placement
Monday 23 December 2024 (3 days ago) • GlobeNewswire Inc.

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
Monday 23 December 2024 (3 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

RAPT Therapeutics Reports Third Quarter 2024 Financial Results
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury
Monday 11 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (5 months ago) • Edgar (US Regulatory)

More RAPT Therapeutics Inc News Articles

Rua Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions